Sodium chloride

The Worldwide Reduced Salt Food Products Industry is Expected to Reach $431.1 Billion by 2028

Retrieved on: 
Sunday, January 22, 2023
Intussusception (medical disorder), Stomach cancer, Sodium chloride, Stroke, Lethargy, Meat, Kidney disease, Health, Hyponatremia, Blood, Vegetable, Cell, Heart failure, Water, Food, COVID-19, Mental toughness, Egg, Meal, Cooking, Market, Osteoporosis, Eating, World Health Organization, Diet, Drinking, Risk, Sodium, Poultry, Salt, Dietary supplement

The "Global Reduced Salt Food Products Market Size, Share & Industry Trends Analysis Report by Type, Distribution Channel, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Reduced Salt Food Products Market Size, Share & Industry Trends Analysis Report by Type, Distribution Channel, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global Reduced Salt Food Products Market size is expected to reach $431.1 billion by 2028, rising at a market growth of 5.0% CAGR during the forecast period.
  • The reduced salt food products market was also impacted due to the closure of manufacturing facilities.
  • As a result, rising consumer awareness of the negative effects of high sodium intake as well as a growing desire for nutrient-dense, healthier food products is driving the reduced salt food products market.

Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain

Retrieved on: 
Wednesday, January 18, 2023
Mental Health, Research, Biotechnology, Other Health, Alternative Medicine, Health, Pharmaceutical, General Health, Science, Inc., Brain, Key finding attacks, Psychedelic drug, PRV, NEO, Biomarker, TD, Ketamine, NYSE, Feasibility study, Central nervous system, Food, Feasibility, PR, Consciousness, Deltoid muscle, Sodium chloride, Pharmaceutical industry, Medical imaging, Kernel

Results from this Cybin-sponsored study are intended to inform the future pathway for this program.

Key Points: 
  • Results from this Cybin-sponsored study are intended to inform the future pathway for this program.
  • “The results from the feasibility study are very promising and provide further insights into the potential of this cutting-edge wearable technology to quantify neural activity and changes in brain biomarkers during the administration of psychedelics.
  • Key Findings from the Feasibility Study:
    Demonstrated ketamine-induced changes to functional brain biomarkers associated with potential therapeutic effects, including alterations in cortical function associated with psychedelic experiences.
  • The feasibility study received U.S. Food and Drug Administration Investigational New Drug authorization in October 2021 and U.S. Institutional Review Board approval in January 2022.

Water softener market size to grow by USD 879.16 million from 2022 to 2027: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio

Retrieved on: 
Monday, January 9, 2023
Projection, USD, Honeywell, Growth, RO, POE, Housing, Soil, Congestion, Sodium chloride, Salt, Nutrient, Water softening, Analysis, Culligan, Environment, Unilever, DIR, Perla, Market share, Water, Whirlpool Corporation, Plant, Hardness, 3M, POU, Groundwater, Urbanization, KENT, Regeneration, Fertilizer, Thermoplastic, Agriculture, Millennials, Geography

Vendor Landscape - The global water softener market is fragmented, with the presence of several global as well as regional vendors.

Key Points: 
  • Vendor Landscape - The global water softener market is fragmented, with the presence of several global as well as regional vendors.
  • By geography, the global water softener market is segmented into North America, Europe, APAC, South America, and the Middle East and Africa.
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global water softener market.
  • Major challenges - The threat to the environment due to salt-based water softener systems is a major challenge for the global water softener market growth.

Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval

Retrieved on: 
Tuesday, December 20, 2022
Biotechnology, Pharmaceutical, Health, Degenerative disease, Security (finance), Bromide, Patient, Central nervous system, Annual report, NYSE, Food, Common stock, Federation, Growth, SVP, COVID-19, Risk, Medication, Generic, FDA, Weather, Nasal spray, Amneal Pharmaceuticals, Sodium chloride, Tachycardia, Investment, Research, Abbreviated New Drug Application, Regulation of tobacco by the U.S. Food and Drug Administration, Pharmaceutical industry, Risk management

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the Company has successfully launched 26 new generic products in 2022.

Key Points: 
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the Company has successfully launched 26 new generic products in 2022.
  • Looking to 2023, we expect more than 30 new product launches,” said Chirag Patel and Chintu Patel, Amneal Co-Chief Executive Officers.
  • In addition, Amneal also announced it received Abbreviated New Drug Application approval from the U.S. Food and Drug Administration (“FDA”) for its first large volume bag, esmolol hydrochloride in sodium chloride injection.
  • According to IQVIA®, U.S. annual sales for this product for the 12 months ended October 2022 were $57 million.

Capstone Announces Authorization of Biosimilar Human Insulin for IV Infusion in Canada and EU

Retrieved on: 
Tuesday, November 29, 2022
Blood, Insulin, European Medicines Agency, Food, European Directive on Traditional Herbal Medicinal Products, Health Canada, Hospital, Partnership, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Committee for Medicinal Products for Human Use, Glucose, FDA, Liver, CHMP, Committee, Sodium chloride, IV, Celerity, Medical device, Pharmaceutical industry, Capstone, EU

ROSEMONT, Ill., Nov. 29, 2022 /PRNewswire/ -- Capstone Development Services Company LLC ("Capstone") announced today that a biosimilar version of human insulin received authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) and a Notice of Compliance from Health Canada. The product is the only ready-to-use insulin for IV infusion. It received approval from the U.S. Food and Drug Administration (FDA) in 2019.

Key Points: 
  • ROSEMONT, Ill., Nov. 29, 2022 /PRNewswire/ -- Capstone Development Services Company LLC ("Capstone") announced today that a biosimilar version of human insulin received authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) and a Notice of Compliance from Health Canada.
  • The product is the only ready-to-use insulin for IV infusion.
  • The ready-to-use insulin is formulated as an IV infusion in a flexible plastic container using human insulin in 0.9% Sodium Chloride injection to be administered to patients in hospitals and other acute care settings.
  • To date, Capstone has developed and gained regulatory approvals on 18 products in the U.S., EU and Canada.

Nick Stenson Beauty to Launch New Line at Ulta Beauty in November

Retrieved on: 
Wednesday, November 2, 2022
Home Goods, Cosmetics, Retail, Women, Seniors, Online Retail, Luxury, Teens, Men, Department Stores, Bridal, LGBTQ+, Specialty, Family, Consumer, Fashion, Animal, Life, Conditioner, Lingo (VoIP Service operator), Ulta Beauty, Industry, Travel, Collection, Empowerment, Ulta, Sodium chloride, Beauty, Education, Creatine, Social media, Paraben, Nutrient, Skin, Hair, Aloe vera, NICK, Multimedia, Jojoba oil, B-12, Antioxidant, Internet, Senior, Stenson, Cosmetics

(Photo: Nick Stenson Beauty)

Key Points: 
  • (Photo: Nick Stenson Beauty)
    The line was created by award-winning global hair stylist and beauty industry leader Nick Stenson, whos passion for beauty is rooted throughout his extensive career.
  • WHAT NICK STENSON BEAUTY IS MADE OF: ALOE VERA, CREATINE + MORE
    All products in the Nick Stenson Beauty hair care collection contain Aloe Vera Gel as the key ingredient.
  • For more tips, how-to demos and ingredient information follow Nick Stenson (@nickstenson) and Nick Stenson Beauty (@nickstensonbeauty), and be fully immersed in the Consciously Curated, Naturally Luxe Nick Stenson Beauty experience.
  • ABOUT NICK STENSON BEAUTY: Nick Stenson Beauty (@nickstensonbeauty) is where nature meets luxury.

CYPRESS DEVELOPMENT ENGAGES THYSSENKRUPP NUCERA FOR DESIGN AND ENGINEERING OF CHLOR-ALKALI PLANT IN FEASIBILITY STUDY

Retrieved on: 
Thursday, October 27, 2022
Lithium, Wood, DLE, Lithium carbonate, ThyssenKrupp, Feasibility study, Bipolar, Cell, Hydrogen chloride, National instrument, Heart, Water, Solution, Hydrochloric acid, Sodium hydroxide, Sodium chloride, Technology, Engineering, Company, MMSA, National Instrument 43-101, Balfour Beatty Infrastructure, Inc., Electrolysis, Project, CEO, Hydrogen, News, Cypress, WSP, Akwa Ibom State Association of Nigeria, USA Inc., Saltern, BC, Chlorine

VANCOUVER, BC, Oct. 27, 2022 /PRNewswire/ - Cypress Development Corp. (TSXV: CYP) (OTCQX: CYDVF) (Frankfurt: C1Z1) (Cypress or Company)is pleased to announce the selection of thyssenkrupp nucera USA, Inc. (thyssenkrupp nucera) to provide the design and engineering for the chlor-alkali plant as part of the ongoing Feasibility Study on the Company's Clayton Valley Lithium Project in Nevada, USA (Project).

Key Points: 
  • VANCOUVER, BC, Oct. 27, 2022 /PRNewswire/ - Cypress Development Corp. (TSXV: CYP) (OTCQX: CYDVF) (Frankfurt: C1Z1) (Cypress or Company)is pleased to announce the selection of thyssenkrupp nucera USA, Inc. (thyssenkrupp nucera) to provide the design and engineering for the chlor-alkali plant as part of the ongoing Feasibility Study on the Company's Clayton Valley Lithium Project in Nevada, USA (Project).
  • "The Company's selection of thyssenkrupp nucera is another important step towards completion of the Feasibility Study for the Project's production of lithium carbonate.
  • Their experience and proven track record as an electrolysis technology company with worldwide knowledge in the chlor-alkali field will add to our Feasibility Study" stated Bill Willoughby, President, and CEO of Cypress Development.
  • thyssenkrupp nucera USA Inc. is the U.S. subsidiary of thyssenkrupp nucera AG & Co. KGaA, an international company that offers world-leading technologies for high-efficiency electrolysis plants, which includes chlor-alkali electrolysis, HCl electrolysis, and alkaline water electrolysis.

Intravenous Solutions Global Market Report 2022: Increasing Prevalence of Diarrhoea Worldwide Driving Demand - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 26, 2022
Health, Medical Supplies, Medical Devices, International Children's Festival at Wolf Trap, Solution, Sodium chloride, Glucose, Prevalence, Emergency fund, CAGR, Dehydration, Patient, UNICEF, Research, First Nations in Ontario, The Lancet, Region, Balance, Decision-making, Disability-adjusted life year, Mineral, Marketing, Industry, Electrolyte, US, United Nations, Application, Water, Malnutrition, Death, Pharmaceutical industry, Diarrhea

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation.

Key Points: 
  • Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation.
  • These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration.
  • There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.
  • Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period.

Global Ion Exchange Resin Market (2022 to 2027) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, September 5, 2022
Other Manufacturing, Manufacturing, Mining, Filtration, Uranium, Agriculture, Sodium chloride, Nitrate, Disinfectant, Water, Ion exchange, Lake, Investment, Fresh water, Ion, Sewage, Water softening, Sodium hydroxide, Hydrochloric acid, Growth, Environment, Food safety, Fire, Resin, Drinking water, Lithium

On the flip side, bacterial contamination caused by ion exchange resins is likley to hinder the growth of the market studied.

Key Points: 
  • On the flip side, bacterial contamination caused by ion exchange resins is likley to hinder the growth of the market studied.
  • The efficacy of ion exchange for water treatment can be limited by mineral scaling, surface clogging, and other issues that contribute to resin fouling.
  • North America is expected to dominate the global ion exchange resin market during the forecast period.
  • This is majorly because of the increasing demand for ion exchange resins from end-user industries including pharmaceutical, mining, and nuclear power.

Epicore Biosystems and Denka Partner to Tackle Asia's Dehydration Crisis Through Sweat-Sensing Wearable Technology

Retrieved on: 
Tuesday, August 30, 2022
Head, Partnership, Heat stroke, University, Fatigue, CEO, Technology, Fortune 500, National Institute, Smartphone, Foundation for the National Institutes of Health, Research, Heat, Perspiration, Solution, Sodium chloride, Organic, Epicore, Northwestern University School of Education and Social Policy, Sport, Department, U.S. Department of Defense Strategy for Operating in Cyberspace, Hospital, Multimedia, Athlete, Dehydration, BioSystems, Connected, PepsiCo, Defense, Climate, Patient, Pharmaceutical industry, Online shopping, Gatorade, Denka, Health

CAMBRIDGE, Mass., Aug. 30, 2022 /PRNewswire/ -- Epicore Biosystems, a digital health company developing advanced sweat-sensing wearables that provide real-time personalized health insights for hydration, stress and wellness, today announced a partnership with Denka Corporation, a Japan-based multinational technology and materials company. Under the agreement, Epicore Biosystems and Denka will collaborate on strategic initiatives to pilot and distribute Epicore's portfolio of advanced wearable hydration solutions in Japan and expand into Asia markets.

Key Points: 
  • Under the agreement, Epicore Biosystems and Denka will collaborate on strategic initiatives to pilot and distribute Epicore's portfolio of advanced wearable hydration solutions in Japan and expand into Asia markets.
  • "As temperatures continue to rise in countries around the globe, dehydration has become a leading cause of concern," said Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems.
  • Our collaboration with Denka enables us to unlock new opportunities and address hydration challenges head-on within the Asia market."
  • Denka and Epicore Biosystems' partnership officially went into effect this month with the goal to bring personalized hydration products to the Asia markets in the next 18 months.